In order to underpin its position among the world’s leading research institutions, the University of Zurich has established its University Research Priority Programs (URPP). The URPP create and promote academic networks in selected areas of research and contribute to the advancement of knowledge in areas of research that benefit society.
IREM is particularly proud that Prof. Janine Reichenbach is part of the new URPP ITINERARE.
ITINERARE: Innovative Therapies in Rare Diseases – Challenges and Opportunities URPP
There is a great need for new therapies to treat rare diseases as well as initiatives that raise the public’s awareness of these conditions. ITINERARE: Innovative Therapies in Rare Diseases – Challenges and Opportunities is a URPP that seeks to advance the development of new therapies for treating rare diseases while also trying to answer the ethical, legal and pedagogical questions that surround these illnesses.
Led by Dr. Janine Reichenbach, Dr. Olivier Devuyst, Dr. Matthias Baumgartner
Kick-off: January 2021
News release, 18 August 2020: UZH Introduces Five New University Research Priority Programs